Oral manifestations, salivary flow rates and Candida species in Thai HIV-infected patients
- PMID: 30805118
- PMCID: PMC6383906
- DOI: 10.4317/jced.55384
Oral manifestations, salivary flow rates and Candida species in Thai HIV-infected patients
Abstract
Background: Effects of various Highly Active Antiretroviral Therapy (HAART) regimens on oral heath are unclear. Objectives: We aimed to evaluate effects of HAART on oral manifestations, salivary flow rates (SFR) and Candida species in HIV-infected patients who took mostly non-protease inhibitor-based HAART regimens.
Material and methods: A cross-sectional study was performed on HIV-infected patients taking and never taken HAART who attended Thai Red Cross AIDS Research Centre (n = 48). Non-HIV subjects were recruited as control (n = 20). Oral conditions and salivary flow rates were evaluated using oral examination and measurement of unstimulated and stimulated saliva. In addition, Candida colonization counts (colony forming units; CFUs) and Candida species from the collected saliva were evaluated using CHROMagar.
Results: The most common oral manifestation in HIV-infected subjects taking HAART was hyperpigmentation. Unstimulated and stimulated SFR among the three groups were not statistically significant. Candida colonization was detected in 64%, 65% and 35% of HIV-infected subjects taking HAART, HAART-naïve, and non-HIV subjects, respectively. While 20% and 35% of HIV-infected subjects with and without HAART, respectively, had Candida CFUs higher than 500/ml, all non-HIV carriers had Candida CFUs lower than 500/ml. The most common Candida colonization species was C. albicans in HAART and non-HIV groups. Interestingly, HAART-naïve group was colonized more by non-albicans species.
Conclusions: HAART has minimal effects on oral health. While HAART may not prevent Candida colonization, it might lead to reduction of non-albicans species. Because maintaining low Candida counts is important, HAART administration and antifungal sensitivity test should be considered in HIV-infected patients. Key words:HIV, Candida, HAART, Oral manifestation, Salivary flow rates.
Conflict of interest statement
Conflict of interest statement:The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Oral hyperpigmentation as an adverse effect of highly active antiretroviral therapy in HIV patients: A systematic review and pooled prevalence.J Clin Exp Dent. 2023 Jul 1;15(7):e561-e570. doi: 10.4317/jced.60195. eCollection 2023 Jul. J Clin Exp Dent. 2023. PMID: 37519321 Free PMC article. Review.
-
Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.Arch Oral Biol. 2014 Aug;59(8):775-82. doi: 10.1016/j.archoralbio.2014.04.010. Epub 2014 Apr 21. Arch Oral Biol. 2014. PMID: 24837476
-
Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.J Oral Pathol Med. 2014 Oct;43(9):696-703. doi: 10.1111/jop.12192. Epub 2014 Jun 14. J Oral Pathol Med. 2014. PMID: 24931443
-
Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.J Oral Pathol Med. 2010 Feb;39(2):188-94. doi: 10.1111/j.1600-0714.2009.00857.x. Epub 2009 Dec 22. J Oral Pathol Med. 2010. PMID: 20040023
-
[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].Parassitologia. 2004 Jun;46(1-2):89-93. Parassitologia. 2004. PMID: 15305694 Review. Italian.
Cited by
-
CD4 cells count as a prognostic marker in HIV patients with comparative analysis of various studies in Asia Pacific region.J Family Med Prim Care. 2020 May 31;9(5):2431-2436. doi: 10.4103/jfmpc.jfmpc_137_20. eCollection 2020 May. J Family Med Prim Care. 2020. PMID: 32754515 Free PMC article.
-
Oral health status of patients infected with human immunodeficiency virus and related factors, Iran: a cross-sectional study.BMC Oral Health. 2021 Dec 18;21(1):657. doi: 10.1186/s12903-021-02002-3. BMC Oral Health. 2021. PMID: 34922512 Free PMC article.
-
How the evolving epidemics of opioid misuse and HIV infection may be changing the risk of oral sexually transmitted infection risk through microbiome modulation.Crit Rev Microbiol. 2020 Feb;46(1):49-60. doi: 10.1080/1040841X.2020.1716683. Epub 2020 Jan 30. Crit Rev Microbiol. 2020. PMID: 31999202 Free PMC article. Review.
-
Oral hyperpigmentation as an adverse effect of highly active antiretroviral therapy in HIV patients: A systematic review and pooled prevalence.J Clin Exp Dent. 2023 Jul 1;15(7):e561-e570. doi: 10.4317/jced.60195. eCollection 2023 Jul. J Clin Exp Dent. 2023. PMID: 37519321 Free PMC article. Review.
-
Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report.J Med Case Rep. 2022 Nov 7;16(1):429. doi: 10.1186/s13256-022-03561-x. J Med Case Rep. 2022. PMID: 36345027 Free PMC article.
References
LinkOut - more resources
Full Text Sources